Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DASCO: DAAs for HCV/HBV Co-infection
NCT02555943Phase 3Completed
- Sponsor
- Humanity & Health Research Centre
- Start
- Feb 2015
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entecavir, tenofovir disoproxil fumarate in hepatitis B (HBV), sponsored by Humanity & Health Research Centre. Started Feb 2015; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT02555943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555943.